Tango Therapeutics, Inc. (TNGX)
12.35
-0.06
(-0.48%)
USD |
NASDAQ |
Feb 19, 16:00
12.34
-0.02
(-0.12%)
Pre-Market: 20:00
Tango Therapeutics EPS Diluted (Quarterly) : 0.1431 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AbbVie, Inc. | 1.024 |
| Teleflex, Inc. | -9.243 |
| Amicus Therapeutics, Inc. | 0.0558 |
| EyePoint Plc | -0.8513 |
| Verastem, Inc. | -1.347 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 15.88M |
| Revenue (Quarterly) | 53.81M |
| Total Expenses (Quarterly) | 37.93M |
| Enterprise Value | 1.544B |
| Gross Profit Margin (Quarterly) | 98.97% |
| Profit Margin (Quarterly) | 29.52% |
| Earnings Yield | -7.42% |
| Normalized Earnings Yield | -7.421 |